Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/AAREYDRUGS stock hub

NSE/AAREYDRUGS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/AAREYDRUGSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.6B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/AAREYDRUGS

In the news

Latest news · NSE/AAREYDRUGS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E76.2

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC0.1

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/AAREYDRUGS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

164

Groups with data

Currency

INR

Showing 164 of 164 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	132
Enterprise value	INR 3.1B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE198H01019
Last refreshed	2026-05-10
Market cap	INR 2.6B
Price	INR 92
Price currency	INR
Rev Per Employee	29,613,333.33x
Sector	Healthcare
Sic	2833
Symbol	nse/AAREYDRUGS
Website	https://www.aareydrugs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.31%
EV Earnings	90.41x
EV/EBITDA	124.09x
EV/Sales	0.79x
P/B ratio	1.76x
P/E ratio	76.21x
P/S ratio	0.67x
PE Ratio10 Y	23.31x
PE Ratio3 Y	36.57x
PE Ratio5 Y	28.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.1%
EBITDA Margin	0.64%
Gross margin	1.67%
Gross Profit	INR 65.5M
Gross Profit Growth	-72.93%
Gross Profit Growth3 Y	-25.84%
Gross Profit Growth5 Y	-10.19%
Net Income	INR 34.4M
Net Income Growth	-39.8%
Net Income Growth Q	-20.68%
Net Income Growth Years	0%
Net Income Growth3 Y	8.92%
Net Income Growth5 Y	-10.86%
Pretax Margin	1.47%
Profit Margin	0.88%
Profit Per Employee	INR 260,227
Profitable Years	18
Roa5y	1.94
Roe5y	4.59
ROIC	0.11
Roic5y	4.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	74.21%
Cagr3y	48.39%
EPS Growth	-42.64
EPS Growth Q	-21.85
EPS Growth Years	0
EPS Growth3 Y	2.88
EPS Growth5 Y	-14.48
Revenue Growth	-32.97x
Revenue Growth Q	-27.93x
Revenue Growth Years	1x
Revenue Growth3 Y	1.23x
Revenue Growth5 Y	6.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 81.9M
Debt	INR 569.6M
Debt EBITDA	INR 22.76
Debt Equity	INR 0.38
Equity	INR 1.5B
Interest Coverage	0.11
Net Cash	INR -487.7M
Net Cash By Market Cap	INR -18.63
Net Debt EBITDA	INR 19.49
Net Debt Equity	INR 0.33
Tangible Book Value	INR 1.5B
Tangible Book Value Per Share	INR 53.06
WACC	7.75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	74.14%
200-day SMA	74.4
3Y total return	226.82%
50-day SMA	73.96
50-day SMA vs 200-day SMA	50under200
All Time High	100
All Time High Change	-8%
All Time High Date	2025-11-06
All Time Low	22
All Time Low Change	318.18%
All Time Low Date	2023-03-27
ATR	4.83
Beta	0.8
Ch YTD	35.95
High	92.4
High52	100
High52 Date	2025-11-06
High52ch	-8%
Low	86.2
Low52	47.76
Low52 Date	2025-06-05
Low52ch	92.63%
Ma50ch	24.4%
Price vs 200-day SMA	23.65%
RSI	65.35
RSI Monthly	59.75
RSI Weekly	62.22
Sharpe ratio	1.26x
Sortino ratio	1.99
Total Return	-4.15%
Tr YTD	35.95
Tr1m	55.41%
Tr1w	0.94%
Tr3m	36.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 3.7M
Operating Income Growth	-96.53
Operating Income Growth3 Y	-60.57
Operating Income Growth5 Y	-44.62
Operating margin	0.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,228,101%
Shares Insiders	39.03%
Shares Institutions	2.78%
Shares Qo Q	0%
Shares Yo Y	4.15%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	226,642.45x
Bv Per Share	53.06
Ch1m	55.41
Ch1w	0.94
Ch1y	74.14
Ch3m	36.95
Ch3y	226.8
Ch6m	-5.41
Change	4.55%
Change From Open	2.7
Close	88
Days Gap	1.8
Depreciation Amortization	21,300,750
Dollar Volume	25,896,436
Earnings Date	2026-05-26
EBIT	INR 3.7M
EBITDA	INR 25M
EPS	INR 1.19
F Score	1
Fiscal Year End	March
Founded	1,990
Graham Number	37.69485
Graham Upside	-59.03
Income Tax	INR 23.2M
Is Primary Listing	0
Last Earnings Date	2026-02-11
Last Report Date	2025-12-31
Lynch Fair Value	INR 6.04
Lynch Upside	-93.44
Ma150	76.5
Ma150ch	20.26%
Ma20	84.82
Ma20ch	8.46%
Next Earnings Date	2026-05-26
Open	89.58
Position In Range	93.55
Price Date	2026-05-08
Price EBITDA	INR 105
Ptbv Ratio	1.76
Relative Volume	1.3x
Revenue	3,908,960,000x
Tax By Revenue	0.59x
Tax Rate	40.36%
Tr6m	-5.41%
Volume	281,483

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/AAREYDRUGS pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/AAREYDRUGS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/AAREYDRUGS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.8%

Share of float held by funds and institutions

Insider ownership

+39.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.2%

Negative means the company is buying back shares.

Technical

NSE/AAREYDRUGS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.3

Neutral momentum band

Price vs 200-day MA

+23.7%

50/200-day relationship not available

Beta (5Y)

0.80

Moves roughly with the market

Sharpe ratio

1.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/AAREYDRUGS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/AAREYDRUGS stock rating?

nse/AAREYDRUGS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/AAREYDRUGS analysis?

The full report lives at /stocks/nse/AAREYDRUGS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/AAREYDRUGS?

The latest report frames nse/AAREYDRUGS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/AAREYDRUGS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.